home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

The Most Common Problems in FDA Software Validation & Verification - Webinar by GlobalCompliancePanel

 
  September 22, 2010  
     
 


GlobalCompliancePanel, Online Training Webinar
2010-10-26


The statement clearly reflects the renewed FDA interest in examining industry compliance with regulations for electronic records and electronic signatures - and its willingness to aggressively pursue enforcement actions.

This FDA Software Validation and Verification (V&V) training/webinar will review the validation planning process with particular emphasis on avoiding most common pitfalls. Software V&V is an extremely important requirement for ensuring the safety and reliability of software used in manufacturing, devices, design, and quality systems. FDA has cited numerous companies on software verification and validation issues in Warning Letters and inspectional observations. The presentation will address some common sense approach to this dilemma without going overboard; such as having V&V plans and processes that clearly define the completion criteria for a product or process step; and to match the V&V process to the product and risk.

Why you should attend:

  • Whether you're planning to audit an internal IT system, anticipating an audit from a customer, preparing for the inevitable FDA inspection, or a vendor wishing to clearly demonstrate a software product is Part 11 compliant, this teleconference will give both old hands and new staff the practical information needed to understand the applicable regulations and solid methods to document compliance.
  • FDA inspectors are now being trained to evaluate software validation practices.
  • Increasing use of automated manufacturing and quality systems means increased exposure.
  • Most recalls can be traced back to computerized equipment, exposing the validation process to scrutiny.
  • A third of recent warning letters included citations with respect to improper or ineffective validation.
  • Many companies struggle with understanding how to avoid major mistakes when validating software to FDA standards. This presentation will review the validation planning process with particular emphasis on avoiding common pitfalls. The attendee should leave the presentation confident in their ability to improve the level of validation success.

Areas Covered In the Seminar:

  • Outline of FDA regulations as applied to software.
  • Review of FDA software validation requirements.
  • Why validation makes good business sense.
  • Most Common Problems in FDA Software Validation & Verification.
  • Strategies on how to avoid the most common problems.
  • Advice on successful validation project staffing.

Who will benefit: This seminar will give valuable help to FDA regulated Pharmaceutical, Medical Device, Biotech, Diagnostics and Biological manufacturers. The staff members who will benefit include:

  • System owners - responsible for keeping individual systems in validation
  • QA / QC managers, executives and personnel
  • Validation specialists
  • Software quality reviewers
  • Consultants
 
 
Organized by: GlobalCompliancePanel
Invited Speakers: Nancy Duarte-Lonnroth; -Nancy, is the Director of Quality & Regulatory Affairs, Healthcare responsible for global coordination of Celestica’s Healthcare Quality, Regulatory and FDA compliance. Nancy is Quality and Regulatory expert with fifteen years experience in regulatory affairs, quality systems, compliance, clinical quality, validation, auditing, quality control, data management systems, post market surveillance, supplier management and regulatory compliance in the areas of bio/pharmaceuticals, medical devices and combination products. Nancy has contributed to the success of both venture and public companies, establishing a track record of successfully achieving timely global regulatory approvals, initiating and effectively managing preclinical and clinical investigations and developing and maintaining effective and compliant quality systems in various healthcare sectors.
 
Deadline for Abstracts: 2010-10-25
 
Registration:

Live live online training only for one participant Price: $245.00

Corporate Live 4 to 10 participants from a single location (For multiple locations contact Customer Care)
Price: $995.00
 

 

E-mail: webinars@GlobalCompliancePanel.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.